Breaking News Instant updates and real-time market news.

CELG

Celgene

$86.95

-1.89 (-2.13%)

, AGIO

Agios Pharmaceuticals

$73.22

-1.23 (-1.65%)

06:27
04/09/18
04/09
06:27
04/09/18
06:27

Celgene M&A targets may include Agios, Jounce, FT reports

Celgene (CELG) is on the hunt for acquisition targets, according to sources cited by the Financial Times. According to a source, Celgene is "absolutely" working on acquisitions to bolster the pipeline as investors press management to conduct further M&A following the recent $9B takeover of cancer cell therapy company Juno. Potential targets include Agios (AGIO) and Jounce (JNCE), according to the sources. Reference Link

CELG

Celgene

$86.95

-1.89 (-2.13%)

AGIO

Agios Pharmaceuticals

$73.22

-1.23 (-1.65%)

JNCE

Jounce Therapeutics

$18.48

-1.23 (-6.24%)

  • 09

    Apr

  • 08

    May

  • 18

    May

  • 30

    May

  • 21

    Aug

CELG Celgene
$86.95

-1.89 (-2.13%)

03/27/18
EVER
03/27/18
NO CHANGE
Target $155
EVER
Outperform
Evercore sees higher chances of Revlimid patent settlement for Celgene
Evercore ISI analyst Umer Raffat believes the odds of a Revlimid patent settlement between Celgene (CELG) and Dr. Reddy's (RDY) have gone up "considerably" following a recent court filing. The filing, according to the analyst, shows Dr. Reddy's agreed to resolve claims construction issues, which he believes "implies a clear alignment in thought process between both sides." A potential settlement on Revlimid remains the biggest catalyst on Celgene in 2018, and could lead a quick re-rating in the valuation multiple, Raffat tells investors in a research note. He keeps Celgene as his top pick for 2018 with an Outperform rating and $155 price target.
03/28/18
03/28/18
NO CHANGE

Bluebird Bio and Celegene to co-develop bb2121 anti-BMCA therapy
Bluebird Bio (BLUE) and Celgene (CELG) announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen, or BCMA chimeric antigen receptor, or CAR, T cell therapy for the potential treatment of patients with relapsed/refractory multiple myeloma in the United States.The companies originally entered into a broad, global strategic research collaboration in 2013 to discover, develop and commercialize novel therapies in oncology, which included bb2121.
03/28/18
LEER
03/28/18
NO CHANGE
Target $123
LEER
Outperform
Leerink sees 60% upside in Celgene shares under 'base case' scenario
Leerink analyst Geoffrey Porges says his sum-of-the-parts analysis suggests Celgene shares are discounting zero cash flow from Revlimid after 2022 and no approval ever of ozanimod or luspatercept. His "base case" scenario, which includes a slow revenue decline for Revlimid post 2022 and ozanimod's approval in multiple sclerosis during 2019 with a 50% probability of success in all indications, results in a net present value of $140 per share, which is 60% above the current share stock price. Celgene closed yesterday down $1.36 to $85.81. Porges' "worst case" scenario, which assumes no Revlimid contribution post 2022 and neither ozanimod nor luspatercept, has the stock worth $87. Celgene shares discounting "such a bad outlook" is no surprise after the company's "recent missteps and misjudgments," but the stock offers "remarkable upside" to investors willing to step in at the current "distressed" valuation," Porges tells investors in a research note. He keeps an Outperform rating on Celgene with a $123 price target.
04/03/18
JMPS
04/03/18
NO CHANGE
JMPS
Market Perform
Celgene COO departure not a surprise, says JMP Securities
JMP Securities analyst Michael King said he was not surprised by the announcement that Celgene COO Scott Smith is exiting given the recent missteps in the company's Inflammation and Immunology franchise. This appears to be the first major step in restructuring Celgene's executive team and he hopes the evolving management structure improves execution and accountability, King tells investors. Although valuation seems to be at extreme lows, King thinks Celgene shares will have a hard time recovering until the company can demonstrate it has regained its ability to drive value, either through execution or an acquisition. He keeps a Market Perform rating on the stock.
AGIO Agios Pharmaceuticals
$73.22

-1.23 (-1.65%)

02/14/18
OPCO
02/14/18
DOWNGRADE
OPCO
Perform
Agios Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
02/14/18
OPCO
02/14/18
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades Agios on valuation after Q4 results
Oppenheimer analyst Leah Rush Cann downgraded Agios Pharmaceuticals to Perform from Outperform following this morning's Q4 results. The analyst, who rescinded her price target, says that while the company's pipeline programs are moving forward, the shares trade inline with her valuation following the substantial rally over the previous 12 months. Cann adds Agios's recent capital raise resulted in approximately 17% dilution.
02/15/18
FBCO
02/15/18
NO CHANGE
Target $80
FBCO
Outperform
Agios Pharmaceuticals price target raised to $80 from $66 at Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Agios Pharmaceuticals to $80 from $66 as she sees upside opportunities in her valuation model related to newly diagnosed success in ivosidenib, PKD, AG-270 and DHODH. The analyst reiterates an Outperform rating on the shares.
02/15/18
RHCO
02/15/18
NO CHANGE
Target $101
RHCO
Buy
Agios Pharmaceuticals price target raised to $101 from $80 at SunTrust
SunTrust analyst Yatin Suneja raised his price target on Agios Pharmaceuticals to $101, citing increasing value of AG-348 that is expected to begin in Q2 of this year. The analyst also points to AG-270 trial starting in Q1 of this year and a perioperative "window" study of ivosidenib/AG-881 in glioma as potential catalysts. Suneja concludes that 4 Agios Pharmaceuticals is "making rapid progress on al fronts", keeping his Buy rating on the stock.
JNCE Jounce Therapeutics
$18.48

-1.23 (-6.24%)

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$11.19

-0.305 (-2.65%)

18:14
08/15/18
08/15
18:14
08/15/18
18:14
Periodicals
Deutsche Bank traders generated $35M on Turkey turmoil, Bloomberg says »

Deutsche Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$18.41

-0.13 (-0.70%)

, CSCO

Cisco

$43.79

-0.22 (-0.50%)

18:06
08/15/18
08/15
18:06
08/15/18
18:06
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Briggs…

BGG

Briggs & Stratton

$18.41

-0.13 (-0.70%)

CSCO

Cisco

$43.79

-0.22 (-0.50%)

NTAP

NetApp

$82.43

-0.335 (-0.40%)

HTGM

HTG Molecular

$3.30

-0.06 (-1.79%)

SPTN

SpartanNash

$23.78

-0.26 (-1.08%)

GNL

Global Net Lease

$22.08

(0.00%)

ILMN

Illumina

$327.57

-2.69 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 21

    Aug

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

  • 16

    Aug

TWTR

Twitter

$32.39

-0.79 (-2.38%)

18:04
08/15/18
08/15
18:04
08/15/18
18:04
Periodicals
Twitter CEO rethinking parts of platform to stop hate speech, fake news, WP says »

Twitter CEO Jack Dorsey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

EADSY

Airbus

$0.00

(0.00%)

18:00
08/15/18
08/15
18:00
08/15/18
18:00
Periodicals
U.S.: EU failed to bring Airbus subsidies in line with WTO ruling, Reuters says »

The U.S. has claimed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$35.40

-0.37 (-1.03%)

17:56
08/15/18
08/15
17:56
08/15/18
17:56
Periodicals
Blackstone in talks to buy interest in Jet Airways loyalty unit, Bloomberg says »

Blackstone is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGA

Pegasystems

$60.00

(0.00%)

17:54
08/15/18
08/15
17:54
08/15/18
17:54
Recommendations
Pegasystems analyst commentary  »

Pegasystems headline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 11

    Sep

  • 12

    Sep

GOOG

Alphabet

$1,213.65

-28.3 (-2.28%)

, GOOGL

Alphabet Class A

$1,232.30

-25.85 (-2.05%)

17:53
08/15/18
08/15
17:53
08/15/18
17:53
Hot Stocks
Google introduces transparency report for political ads »

Alphabet's Google…

GOOG

Alphabet

$1,213.65

-28.3 (-2.28%)

GOOGL

Alphabet Class A

$1,232.30

-25.85 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

NAVB

Navidea

$0.14

-0.013 (-8.70%)

17:49
08/15/18
08/15
17:49
08/15/18
17:49
Hot Stocks
Navidea receives noncompliance notice from NYSE American »

Navidea…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

PNC

PNC Financial

$142.03

-0.7 (-0.49%)

17:48
08/15/18
08/15
17:48
08/15/18
17:48
Periodicals
Breaking Periodicals news story on PNC Financial »

PNC faces subpoena over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

RCI

Rogers Communications

$52.16

0.13 (0.25%)

17:45
08/15/18
08/15
17:45
08/15/18
17:45
Hot Stocks
Rogers Communications declares quarterly dividend of CAD 48c per share »

The quarterly dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEX

IDEX Corp.

$151.57

-0.375 (-0.25%)

17:41
08/15/18
08/15
17:41
08/15/18
17:41
Hot Stocks
IDEX Corp. CFO William Grogan sells over $520K in company stock »

IDEX Corp. CFO William…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$350.54

-18.07 (-4.90%)

17:37
08/15/18
08/15
17:37
08/15/18
17:37
Hot Stocks
Align Technology VP Stuart Hockridge sells over $1M in company stock »

Align Technology VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

SYMC

Symantec

$18.56

-0.1 (-0.54%)

17:34
08/15/18
08/15
17:34
08/15/18
17:34
Hot Stocks
Symantec says provided intelligence to FBI for 74 cybercriminal arrests »

Symantec said that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

CAAP

Corporacion America Airport

$9.15

-0.18 (-1.93%)

17:28
08/15/18
08/15
17:28
08/15/18
17:28
Hot Stocks
Corporacion America Airports reports July passenger traffic up 7.8% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ALGN

Align Technology

$350.54

-18.07 (-4.90%)

17:22
08/15/18
08/15
17:22
08/15/18
17:22
Hot Stocks
Align Technology CEO sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

ACXM

Acxiom

$44.05

-0.01 (-0.02%)

17:21
08/15/18
08/15
17:21
08/15/18
17:21
Hot Stocks
Acxiom CFO sells 72,783 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MDXG

MiMedx

$3.97

-0.1 (-2.46%)

17:15
08/15/18
08/15
17:15
08/15/18
17:15
Hot Stocks
MiMedx receives additional Nasdaq listing notice »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

DL

China Distance Education

$7.85

-0.36 (-4.38%)

17:11
08/15/18
08/15
17:11
08/15/18
17:11
Earnings
China Distance Education Q3 non-GAAP net income up 68.8% to $5.8M vs. $3.4M y/y »

Reports Q3 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

BPY

Brookfield Property

$19.71

0.06 (0.31%)

, GGP

GGP

$21.41

-0.02 (-0.09%)

17:02
08/15/18
08/15
17:02
08/15/18
17:02
Hot Stocks
Brookfield Property reminds GGP shareholders to make, submit elections »

Brookfield Property…

BPY

Brookfield Property

$19.71

0.06 (0.31%)

GGP

GGP

$21.41

-0.02 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$29.30

-2.05 (-6.54%)

16:45
08/15/18
08/15
16:45
08/15/18
16:45
Hot Stocks
Scientific Games Perelman buys 175K shares of common stock for $5.55M »

Scientific Games chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$180.30

-1.2 (-0.66%)

16:44
08/15/18
08/15
16:44
08/15/18
16:44
Earnings
CACI backs FY19 EPS view $8.98-$9.38, consensus $9.18 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CACI

CACI

$180.30

-1.2 (-0.66%)

16:44
08/15/18
08/15
16:44
08/15/18
16:44
Earnings
CACI reports Q4 EPS ex-tax reform $1.84, consensus $1.79 »

Reports Q4 GAAP EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BGG

Briggs & Stratton

$18.41

-0.13 (-0.70%)

16:43
08/15/18
08/15
16:43
08/15/18
16:43
Earnings
Briggs & Stratton sees FY19 EPS $1.35-$1.55, consensus $1.25 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

NSP

Insperity

$110.70

-1.2 (-1.07%)

16:42
08/15/18
08/15
16:42
08/15/18
16:42
Hot Stocks
Insperity COO Arthur Arizpe sells $565K in company stock »

Insperity COO Arthur…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$18.41

-0.13 (-0.70%)

16:42
08/15/18
08/15
16:42
08/15/18
16:42
Earnings
Briggs & Stratton reports Q4 adjusted EPS 47c, consensus 41c »

Reports Q4 revenue $502M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.